Ridaforolimus in Patients With Hepatic Insufficiency (MK-8669-046)
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacokinetics of ridaforolimus including the area under the
concentration-time curve (AUC[0-infinity]) and maximum concentration (Cmax) after
administration of a single dose of ridaforolimus in patients with moderate hepatic
insufficiency and healthy matched control subjects.